ProQR Therapeutics (PRQR) Cash from Operations Growth (3y) (2016 - 2026)
ProQR Therapeutics (PRQR) Cash from Operations Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | - |
| 10 | ProQR Therapeutics | 187.02 Mn | 94.73 Mn | - | -31.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.18% |
| Dec 31, 2025 | 5.28% |
| Sep 30, 2025 | 7.31% |
| Jun 30, 2025 | 6.98% |
| Mar 31, 2025 | 7.16% |
| Dec 31, 2024 | -68.33% |
| Sep 30, 2024 | 11.12% |
| Jun 30, 2024 | 11.68% |
| Mar 31, 2024 | -8.76% |
| Dec 31, 2023 | 32.13% |
| Sep 30, 2023 | 5.07% |
| Jun 30, 2023 | -1.70% |
| Mar 31, 2023 | 1,337.47% |
| Dec 31, 2022 | -14.26% |
| Sep 30, 2022 | -20.54% |
| Jun 30, 2022 | -10.92% |
| Mar 31, 2022 | -18.29% |
| Dec 31, 2021 | 682.42% |
| Sep 30, 2021 | -14.28% |
| Jun 30, 2021 | -13.20% |